0QB4.LSE Medios AG

Healthcare Commercial Services & Supplies London Exchange
14.34 EUR
Close of Nov 3, 2026
10.00 17.44
Market cap
EUR 196M
P/E
24.3x
P/B
-
ROE
3.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0QB4.LSE undervalued?

Graham number

The Graham number of Medios AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medios AG fundamental analysis

No fundamental analysis for Medios AG yet.

Medios AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers a…

Full company profile